Cost-Effectiveness As A Price Control

摘要: After a technology is developed, cost-effectiveness analysis can offer an economically sound approach to adoption decisions. Little attention has been paid, however, the incentives these criteria induce for getting technologies market in first place. We argue that procedures more fully take into account key trade-off inherent research and development: decreased welfare of current patients as result higher prices versus increased future innovation such provide. Empirical evidence from case study HIV/AIDS provides illustration our conclusions.